Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharbita is a pharmaceutical service provider based in the Netherlands that specializes in Chemistry, Manufacturing, and Controls (CMC) services and clinical trial material manufacturing. The company provides a comprehensive suite of services including analytical development, stability testing, and small-scale GMP manufacturing for Phase 1 and Phase 2 clinical trials. Founded in 1989, Pharbita established itself as a key partner for biotech and pharmaceutical companies navigating the transition from pre-clinical research to human clinical trials. In 2007, the company was acquired by Eurofins Scientific, and it now operates as part of the Eurofins BioPharma Product Testing network, continuing to offer specialized technical and regulatory support for drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharbita.